Shana Hughes1, Nicolas Sheon1, Bob Siedle-Khan1, Brian Custer2,3. 1. UCSF Center for AIDS Prevention Studies, San Francisco, CA. 2. Blood Systems Research Institute, San Francisco, CA. 3. Department of Laboratory Medicine, UCSF, San Francisco, CA.
Abstract
BACKGROUND: Indefinite deferral from donation for any man who discloses having had sex with another man even once since 1977 (MSM77) is the US FDA's standing policy. This qualitative component of the Blood Donation Rules and Opinion Study was designed to provide insight into the perceptions and practices of current or previous donors with MSM history. STUDY DESIGN AND METHODS: Forty human immunodeficiency virus (HIV)-negative MSM completed an online survey, indicating that they had donated blood and were willing to be interviewed. Semistructured, individual interviews with these key informants covered donation experience and motivations, perceptions of MSM77, policy change preferences, and possible impact of a change to a time-limited deferral. Transcripts were coded deductively and inductively, following a modified Grounded Theory approach. Analysis identified recurrent and divergent themes. RESULTS: Ninety-five percent of participants endorsed modifying MSM77. Preferred deferral length ranged from none to 5 years; a common opinion was that a science-based deferral period would be less than 1 year. Other policy change recommendations included incorporating questions about specific HIV risk behaviors to the donor questionnaire for all potential donors. Interviewees recognized HIV infection rates are higher in MSM than the general US population, but participants considered themselves low-risk for HIV, donated blood "to save lives," and justified their recommendations as being more effective ways to identify donors at risk for HIV. CONCLUSION: Results suggest that MSM donors are concerned with blood safety; they can be appealed to as such. Communications about a new deferral policy should include scientific explanations and acknowledge altruistic motivations of potential donors.
BACKGROUND: Indefinite deferral from donation for any man who discloses having had sex with another man even once since 1977 (MSM77) is the US FDA's standing policy. This qualitative component of the Blood Donation Rules and Opinion Study was designed to provide insight into the perceptions and practices of current or previous donors with MSM history. STUDY DESIGN AND METHODS: Forty human immunodeficiency virus (HIV)-negative MSM completed an online survey, indicating that they had donated blood and were willing to be interviewed. Semistructured, individual interviews with these key informants covered donation experience and motivations, perceptions of MSM77, policy change preferences, and possible impact of a change to a time-limited deferral. Transcripts were coded deductively and inductively, following a modified Grounded Theory approach. Analysis identified recurrent and divergent themes. RESULTS: Ninety-five percent of participants endorsed modifying MSM77. Preferred deferral length ranged from none to 5 years; a common opinion was that a science-based deferral period would be less than 1 year. Other policy change recommendations included incorporating questions about specific HIV risk behaviors to the donor questionnaire for all potential donors. Interviewees recognized HIV infection rates are higher in MSM than the general US population, but participants considered themselves low-risk for HIV, donated blood "to save lives," and justified their recommendations as being more effective ways to identify donors at risk for HIV. CONCLUSION: Results suggest that MSM donors are concerned with blood safety; they can be appealed to as such. Communications about a new deferral policy should include scientific explanations and acknowledge altruistic motivations of potential donors.
Authors: R J Benjamin; C Bianco; M Goldman; C R Seed; H Yang; J Lee; A J Keller; S Wendel; S Biagini; J Murray; D V Devine; Y Zhu; P Turek; F M Moftah; R Kullaste; J Pillonel; B Danic; F Bigey; G Folléa; E Seifried; M M Mueller; C K Lin; R N Makroo; G Grazzini; S Pupella; C Velati; K Tadokoro; A Bravo Lindoro; A D'Artote González; V T Giner; P Flanagan; R W Olaussen; M Letowska; A Rosiek; R Poglod; E Zhiburt; P Mali; P Rozman; S Gulube; E Castro Izaguirre; B Ekermo; S M Barnes; L McLaughlin; A F Eder; S Panzer; H W Reesink Journal: Vox Sang Date: 2011-11 Impact factor: 2.144
Authors: C R Seed; T T Lucky; D Waller; H Wand; J F Lee; S Wroth; A McDonald; J Pink; D P Wilson; A J Keller Journal: Vox Sang Date: 2013-10-10 Impact factor: 2.144
Authors: Brian Custer; Debra Kessler; Farnaz Vahidnia; German Leparc; David E Krysztof; Beth Shaz; Hany Kamel; Simone Glynn; Roger Y Dodd; Susan L Stramer Journal: Transfusion Date: 2014-12-04 Impact factor: 3.157
Authors: Ana M Sanchez; George B Schreiber; Catharie C Nass; Simone Glynn; Debra Kessler; Nora Hirschler; Joy Fridey; James Bethel; Edward Murphy; Michael P Busch Journal: Transfusion Date: 2005-03 Impact factor: 3.157
Authors: A E Williams; R A Thomson; G B Schreiber; K Watanabe; J Bethel; A Lo; S H Kleinman; C G Hollingsworth; G J Nemo Journal: JAMA Date: 1997-03-26 Impact factor: 56.272
Authors: Anna E Wentz; Roland C Merchant; Melissa A Clark; Tao Liu; Joshua G Rosenberger; José A Bauermeister; Kenneth H Mayer Journal: Public Health Rep Date: 2018-12-07 Impact factor: 2.792
Authors: Elisabeth Vesnaver; Mindy Goldman; Sheila O'Brien; Paul MacPherson; Terrie Butler-Foster; Don Lapierre; Joanne Otis; Dana V Devine; Marc Germain; Andrew Rosser; Richard MacDonagh; Taylor Randall; William Osbourne-Sorrell; Broderic Clement-Thorne; Taim Bilal Al-Bakri; Kyle A Rubini; Nolan E Hill; Justin Presseau Journal: Health Res Policy Syst Date: 2020-11-02
Authors: Gisell Castillo; Elisabeth Vesnaver; Emily Gibson; Terrie Butler-Foster; Mindy Goldman; Nolan E Hill; Andrew Rosser; Don Lapierre; Kyle A Rubini; Richard MacDonagh; Glenndl Miguel; Amelia Palumbo; Paul MacPherson; Taylor Randall; William Osbourne-Sorrell; Sheila F O'Brien; William Bridel; Joanne Otis; Mark Greaves; Taim Bilal Al-Bakri; Marco Reid; Maximilian Labrecque; Marc Germain; Shane Orvis; Andrew T Clapperton; Dana Devine; Justin Presseau Journal: Transfusion Date: 2022-07-14 Impact factor: 3.337